Remove 2022 Remove Marketing Remove Therapy
article thumbnail

Wellness Marketing: The Future Of Marketing For Wellness Industry

American Esthetician Organization

Are you looking to learn more about the latest trends in wellness marketing? This post explores everything you need to know about wellness marketing and how companies are leveraging consumer interest in improving overall well-being. Wellness industry is projected to reach $7 trillion by 2025.

article thumbnail

BioPhotas, Inc.  Makers of Celluma LED Light Therapy Devices Strengthens Management Team

Lipgloss and Aftershave

the market leader in therapeutic LED Light Therapy devices announced today that its Board of Directors has named Curtis A. During this time, Denise has developed a strong network and clinical expertise with respect to the field of light therapy. BioPhotas, Inc., Cluff as the Company’s CEO.

article thumbnail

The Device This Esthetician Uses in 99% of Treatments

Lipgloss and Aftershave

She’s also a huge fan of Celluma LED Light Therapy devices and uses them in 99% of her treatments! Thanks to Celluma LED Light Therapy for sponsoring this content so that L+A can share Tiffany’s story with our community. Her last chemotherapy treatment was on September 6, 2022. I could tell she was instantly calming.

article thumbnail

Biosimilar News: Stada, Alvotech Launch the First Ustekinumab Biosimilar Across Europe

The Dermatology Digest

Launching Uzpruvo at the earliest opportunity in Europe’s largest pharmaceutical markets, promotes access by creating competition,” says STADA CEO Peter Goldschmidt in a news release. We are delighted at the launch of Uzpruvo in Europe and to be first-to-market,” adds Robert Wessman, Chief Executive Officer of Alvotech.

article thumbnail

Does NAD+ IV “Drip” Therapy Work?

Aesthetics Advisor

Key Points: A few studies show that NAD+ IV therapy can alleviate alcohol and drug addiction, as well as Parkinson’s disease, but no studies have examined its effects on aging. Oral administration of NAD+ boosting therapy is safer, more cost effective, and more consistently dosed than intravenous administartion.

Therapy 36
article thumbnail

Study: The Number of New Dermatology Drugs Approved by the FDA Is on the Rise

The Dermatology Digest

Food and Drug Administration (FDA) increased between 2012 and 2022 compared with prior decades, according to a research letter in JAMA Dermatology. Researchers did not include reformulations of already marketed drugs or indications, such as a new topical formulation of an oral drug.

article thumbnail

Are we witnessing the end of the CBD craze?

Spa Executive

“Overblown marketing claims” and too many players on the market. The market was quickly saturated, despite legal ambiguities in many regions and a lack of regulatory framework in the USA. NPI also reported that CBD marketers are facing financial challenges with decreased earnings and downsizing.

Legal 52